| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | Director | Stock Option (Right to Buy) | 22.4K | $338K | $15.04 | Feb 3, 2025 | Direct |
| ROCKET PHARMACEUTICALS, INC. | Director | Common Stock | 30K | $236K | $7.86 | Jun 18, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| RCKT | ROCKET PHARMACEUTICALS, INC. | Jun 18, 2025 | 1 | $0 | 4 | Jul 18, 2025 | Director |
| RCKT | ROCKET PHARMACEUTICALS, INC. | Feb 3, 2025 | 2 | $0 | 4 | Feb 5, 2025 | Director |
| RCKT | ROCKET PHARMACEUTICALS, INC. | Jan 27, 2025 | 0 | $0 | 3 | Feb 5, 2025 | Director |